Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P634. Incidence of microscopic colitis 2008–2011 in central Östergötland, Sweden. Evidence for an increase?
Authors:

N. Daferera1, S. Almer1, A. Münch1, 1University Hospital, Gastroenterology, Linköping, Sweden

P634

What Are The Long Term Outcomes of Perianal Crohn's Fistulae Treated with Anti-TNF Therapies?

Authors:

N.A. Yassin*1, A. Askari2, L. Ferrari2, J. Warusavitarne2, O. Faiz2, R. Phillips2, A. Hart3

1St Mark's Hospital, Colorectal Surgery & IBD Unit, London, United Kingdom, 2St Mark's Hospital, Colorectal Surgery, London, United Kingdom, 3St Mark's Hospital, IBD Unit, London, United Kingdom

P635.

Comorbidity related hospitalizations in inflammatory bowel disease patients; the importance of urological complications in Crohn's disease

Authors:

M. Crncevic Urek, S. Cukovic-Cavka, R. Prijic, N. Turk, M. Brinar, Z. Krznaric, B. Vucelic, University Hospital Centre Zagreb, Division of Gastroenterology and Hepatology, Zagreb, Croatia

P635. Incidence of inflammatory bowel disease in a private medical institution of Uruguay
Authors:

G. Buenavida1, A. Silveira2, B. Iade1, 1School of Medicine, Gastroenterology, Montevideo, Uruguay, 2School of Medicine, Department of Quantitative Methods, Montevideo, Uruguay

P635

Mean platelet volume and neutrophil-to-lymphocyte ratio as new biomarkers of predicting response to infliximab therapy in Crohn's Disease patients

Authors:

N. Ben Mustapha*, M. Mahmoudi, M. Bejaoui, A. Laabidi, M. Serghini, L. Kallel, M. Fekih, S. Matri, J. Boubaker, A. Filali

La Rabta Hospital, Gastroenterology A, Tunis, Tunisia

P636.

Colorectal cancers in Indian patients with ulcerative colitis

Authors:

D. Desai, A. Deshmukh, P. Abraham, A. Joshi, S. Shah, T. Gupta, R. Deshpande, V. Khandagale, S. George, P D Hinduja Hospital, Veer Savarkar Marg, Mahim, Mumbai, 400016, India, Gastroenterology, Mumbai, India

P636. Incidence of inflammatory bowel disease in Kaunas region, Lithuania
Authors:

G. Kiudelis1, L. Jonaitis1, A. Tamelis2, L. Kupcinskas1, 1Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 2Lithuanian University of Health Sciences, Department of Surgery, Kaunas, Lithuania

P636

Which is the real life maintenance mesalazine dose in ulcerative colitis

Authors:

A. Algaba*1, I. Guerra1, A. García- García de Paredes2, M. de Lucas1, C. Ferre2, D. Bonillo1, L. Aguilera2, A. López-Sanromán2, F. Berrmejo1

1Hospital Universitario de Fuenlabrada, Gastroenterology, Madrid, Spain, 2Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain

P637.

Clostridium difficile infection rate in inflammatory bowel disease patients in a tertiary center in Israel

Authors:

N. Maharshak, A. Ofer, O. Davidov, I. Dotan, Tel Aviv Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel

P637. Incidence and clinical characteristics of inflammatory bowel disease in the Faroe Islands during 2005–2009
Authors:

K.R. Nielsen1, S. Jacobsen2, K. Olsen1, T. Jess3, S. Gaini1, 1National Hospital of the Faroe Islands, Medical Department, Tórshavn, Faroe Islands, 2Genetic Biobank, Tórshavn, Faroe Islands, 3Statens Serum Institut, Department of Epidemiology Research, Denmark

P637

Anti-TNF alpha therapy in Inflammatory Bowel Disease - safety profile in elderly patients

Authors:

C. Bernardes*, D. Carvalho, P. Russo, J. Saiote, J. Ramos

Hospital de Sto António dos Capuchos, Gastroenterology, Lisbon, Portugal

P638.

Characteristics of Gipsy pediatric patients with inflammatory bowel disease (IBD) based on the nationwide, prospective Hungarian pediatric IBD registry (HUPIR)

Authors:

G. Veres1, HUPIR Registry1, K. Koós1, M. Papp2, P. Lakatos3, 1Semmelweis University, Ist Pediatrics, Budapest, Hungary, 2Debrecen, Ist Dept. of Medicine, Debrecen, Hungary, 3Semmelweis University, Ist Dept of Medicine, Budapest, Hungary

P638. Impact of extra-intestinal cancer diagnosis and treament on inflammatory bowel disease outcome
Authors:

S. Rajca1, A. Bourrier1, H. Sokol1, L. Beaugerie1, I. Nion-Larmurier1, P. Seksik1, J. Cosnes1, 1St Antoine hospital, Gastroenterology, Paris, France

P638

Biologic therapy is safe and effective in inflammatory bowel disease (IBD) patients with previous cancer. Experience of a single tertiary IBD center

Authors:

I. Bar-Yishay*, Y. Ron, E. Santo, I. Dotan

Tel Aviv Sourasky medical Center, Sackler School of Medicine, Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel-Aviv, Israel

P639.

Caesarean section is associated with a younger age at IBD diagnosis and a higher proportion of Crohn's disease vs. ulcerative colitis – data from the Swiss IBD Cohort Study

Authors:

L. Biedermann1, N. Fournier2, C.N. Manser1, P. Frei1,3, J. Zeitz1, B. Misselwitz1, V. Pittet2, M. Fried1, C.P. Braegger4, S.R. Vavricka1,5, G. Rogler1, 1University Hospital Zurich, Gastroenterology & Hepatology, Zurich, Switzerland, 2University of Lausanne, IUMSP, Lausanne, Switzerland, 3Seespital Horgen, Gastroenterology & Hepatology, Horgen, Switzerland, 4University Children's Hospital Zurich, Division of Gastroenterology and Nutrition, Zurich, Switzerland, 5Hospital Triemli, Gastroenterology & Hepatology, Zurich, Switzerland

P639. Influence of extraintestinal manifestations in health-related quality of life in inflammatory bowel disease patients
Authors:

M. Barreiro-de Acosta1, M. Iglesias-Rey1, A. Lorenzo1, J.E. Dominguez-Munoz1, 1University Hospital, Gastroenterology, Santiago, Spain

P639

The use of biological therapies in managing patients with IBD in Iraq.

Authors:

A.K.Q. Al-Rubaye, L. Alrubaiy*

Basra Health Directorate, Family Medicine, Basra, Iraq

P640.

A prospective population-based natural history registry of newly diagnosed IBD identifies high rates of severe disease and immunomodulator use after 1 year

Authors:

O. Niewiadomski1, J. Ding1, J. McNeill2, K. Ross3, P. Dabkowski3, C. Hair3, E. Prewett3, S. Alexander3, D. Dowling3, B. Popp4, B. Allen3, J. Wilson1, C. Studd1, P. Desmond1, W. Connell1, S. Bell1, 1St Vincent's Hospital, Gastroenterology, Fitzroy, Australia, 2Monash University, Preventative Medicine and Public Health, Melbourne, Australia, 3Barwon Health, Gastroenterology, Geelong, Australia, 4St John of God Pathology, Pathology, Geelong, Australia

P640. Inflammatory bowel disease demographic and clinical characteristics – findings from a tertiary care center in Romania
Authors:

R. Zaharie1, V. Andreica1, A. Tantau1, F. Zaharie1, T. Mocan1, M. Tantau1, 1University of Medicine and Pharmacy Cluj-Napoca, Medicine-gastroenterology, Cluj-Napoca, Romania

P640

Smoking is associated with higher healthcare costs in IBD patients, primarily due to more frequent anti-TNFalpha use

Authors:

M. Severs*1, M.E. van der Valk1, M.-J. Mangen2, M. van der Have1, G. Dijkstra3, A.A. van Bodegraven4, 5, H.H. Fidder1, D.J. de Jong6, M. Pierik7, J. van der Woude8, M.J.L. Romberg- Camps4, C.H.M. Clemens9, J.M. Jansen10, P.C. van de Meeberg11, N. Mahmmod12, A.E. van der Meulen- de Jong13, C.Y. Ponsioen14, C.J. Bolwerk15, J.R. Vermeijden16, P.D. Siersema1, M. Leenders1, B. Oldenburg1

1University Medical Centre Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands, 2University Medical Centre Utrecht, Julius center for health sciences and primary care, Utrecht, Netherlands, 3University Medical Centre Groningen, Gastroenterology and Hepatology, Groningen, Netherlands, 4ORBIS medical center, Gastroenterology and Hepatology, Sittard, Netherlands, 5VU medical center, Gastroenterology and Hepatology, Amsterdam, Netherlands, 6University Medical Center st. Radboud, Gastroenterology and Hepatology, Nijmegen, Netherlands, 7University Medical Center Maastricht, Gastroenterology and Hepatology, Maastricht, Netherlands, 8Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands, 9Diaconessenhuis, Gastroenterology and Hepatology, Leiden, Netherlands, 10Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, Netherlands, 11Slingeland Hospital, Gastroenterology and Hepatology, Doetinchem, Netherlands, 12Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands, 13Leiden University Medical Centre, Gastroenterology and Hepatology, Leiden, Netherlands, 14Academic Medical Centre Amsterdam, Gastroenterology and Hepatology, Amsterdam, Netherlands, 15Reinier de Graaf Groep, Gastroenterology and Hepatology, Delft, Netherlands, 16Meander Medical Centre, Gastroenterology and Hepatology, Amersfoort, Netherlands